nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethacrynic acid—GSTA2—Transcriptional activation by NRF2—NFE2L2—esophageal cancer	0.0348	0.0545	CbGpPWpGaD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—esophageal cancer	0.0326	0.0511	CbGpPWpGaD
Ethacrynic acid—Apprehension—Cisplatin—esophageal cancer	0.0319	0.152	CcSEcCtD
Ethacrynic acid—ATP1A1—Ion transport by P-type ATPases—ATP1B2—esophageal cancer	0.0245	0.0384	CbGpPWpGaD
Ethacrynic acid—GSTA2—Glutathione conjugation—GSTO1—esophageal cancer	0.0213	0.0334	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Ion transport by P-type ATPases—ATP4A—esophageal cancer	0.0213	0.0333	CbGpPWpGaD
Ethacrynic acid—GSTA2—Transcriptional activation by NRF2—HMOX1—esophageal cancer	0.0207	0.0324	CbGpPWpGaD
Ethacrynic acid—GSTA2—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.0204	0.032	CbGpPWpGaD
Ethacrynic acid—ATP1A1—exocrine gland—esophageal cancer	0.0194	0.128	CbGeAlD
Ethacrynic acid—ATP1A1—Preimplantation Embryo—AQP3—esophageal cancer	0.0175	0.0274	CbGpPWpGaD
Ethacrynic acid—GSTA2—Glutathione conjugation—GSTT1—esophageal cancer	0.0165	0.0259	CbGpPWpGaD
Ethacrynic acid—GSTA2—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.0163	0.0256	CbGpPWpGaD
Ethacrynic acid—GSTA2—epithelium—esophageal cancer	0.0159	0.105	CbGeAlD
Ethacrynic acid—GSTA2—bronchus—esophageal cancer	0.0157	0.103	CbGeAlD
Ethacrynic acid—SLC12A1—epithelium—esophageal cancer	0.0145	0.0955	CbGeAlD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—esophageal cancer	0.0142	0.0223	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—ALDH3A1—esophageal cancer	0.0129	0.0203	CbGpPWpGaD
Ethacrynic acid—ALB—Recycling of bile acids and salts—SLC10A2—esophageal cancer	0.0125	0.0196	CbGpPWpGaD
Ethacrynic acid—ATP1A1—neck—esophageal cancer	0.0124	0.0817	CbGeAlD
Ethacrynic acid—GSTA2—digestive system—esophageal cancer	0.0121	0.0799	CbGeAlD
Ethacrynic acid—ATP1A1—Preimplantation Embryo—SOX2—esophageal cancer	0.0118	0.0185	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—BLVRB—esophageal cancer	0.0115	0.0181	CbGpPWpGaD
Ethacrynic acid—GSTA2—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.0108	0.017	CbGpPWpGaD
Ethacrynic acid—GSTA2—lung—esophageal cancer	0.0101	0.0667	CbGeAlD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—esophageal cancer	0.00984	0.0154	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—PRDX1—esophageal cancer	0.00981	0.0154	CbGpPWpGaD
Ethacrynic acid—GSTA2—Phase II conjugation—GSTO1—esophageal cancer	0.00948	0.0149	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—SLC39A6—esophageal cancer	0.00874	0.0137	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Ion channel transport—ATP1B2—esophageal cancer	0.00849	0.0133	CbGpPWpGaD
Ethacrynic acid—ATP1A1—epithelium—esophageal cancer	0.00843	0.0556	CbGeAlD
Ethacrynic acid—GSTA2—NRF2 pathway—ADH7—esophageal cancer	0.00834	0.0131	CbGpPWpGaD
Ethacrynic acid—ATP1A1—bronchus—esophageal cancer	0.0083	0.0547	CbGeAlD
Ethacrynic acid—ATP1A1—smooth muscle tissue—esophageal cancer	0.00812	0.0536	CbGeAlD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—BAX—esophageal cancer	0.00766	0.012	CbGpPWpGaD
Ethacrynic acid—ATP1A1—trachea—esophageal cancer	0.00745	0.0492	CbGeAlD
Ethacrynic acid—ATP1A1—Ion channel transport—ATP4A—esophageal cancer	0.00736	0.0115	CbGpPWpGaD
Ethacrynic acid—GSTA2—Phase II conjugation—GSTT1—esophageal cancer	0.00735	0.0115	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—ADH7—esophageal cancer	0.00732	0.0115	CbGpPWpGaD
Ethacrynic acid—GSTA2—Transcriptional activation by NRF2—PIK3CA—esophageal cancer	0.00669	0.0105	CbGpPWpGaD
Ethacrynic acid—Hyperuricaemia—Cisplatin—esophageal cancer	0.0066	0.0314	CcSEcCtD
Ethacrynic acid—ALB—Bile acid and bile salt metabolism—SLC10A2—esophageal cancer	0.00654	0.0102	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—ADH1B—esophageal cancer	0.00641	0.0101	CbGpPWpGaD
Ethacrynic acid—ATP1A1—digestive system—esophageal cancer	0.00641	0.0423	CbGeAlD
Ethacrynic acid—Pain—Carboplatin—esophageal cancer	0.00637	0.0303	CcSEcCtD
Ethacrynic acid—Blood uric acid increased—Cisplatin—esophageal cancer	0.00624	0.0296	CcSEcCtD
Ethacrynic acid—SLC12A1—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00607	0.00951	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—ABCC2—esophageal cancer	0.00606	0.0095	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—CYP26A1—esophageal cancer	0.00596	0.00935	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Carboplatin—esophageal cancer	0.00589	0.028	CcSEcCtD
Ethacrynic acid—GSTA2—NRF2 pathway—NFE2L2—esophageal cancer	0.00563	0.00883	CbGpPWpGaD
Ethacrynic acid—SLC12A1—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00555	0.0087	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—GSTO1—esophageal cancer	0.00554	0.00869	CbGpPWpGaD
Ethacrynic acid—ATP1A1—lung—esophageal cancer	0.00536	0.0353	CbGeAlD
Ethacrynic acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.00507	0.00795	CbGpPWpGaD
Ethacrynic acid—Deafness—Cisplatin—esophageal cancer	0.00497	0.0236	CcSEcCtD
Ethacrynic acid—GSTA2—NRF2 pathway—CYP2A6—esophageal cancer	0.00484	0.00759	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.00464	0.00727	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—ALDH2—esophageal cancer	0.00452	0.00709	CbGpPWpGaD
Ethacrynic acid—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.00445	0.0211	CcSEcCtD
Ethacrynic acid—GSTA2—Biological oxidations—GSTT1—esophageal cancer	0.0043	0.00674	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—CYP2A6—esophageal cancer	0.00425	0.00666	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—PTGS1—esophageal cancer	0.00403	0.00632	CbGpPWpGaD
Ethacrynic acid—ALB—lymph node—esophageal cancer	0.0038	0.0251	CbGeAlD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.00369	0.00578	CbGpPWpGaD
Ethacrynic acid—Abdominal discomfort—Cisplatin—esophageal cancer	0.00368	0.0175	CcSEcCtD
Ethacrynic acid—ATP1A1—lymph node—esophageal cancer	0.00366	0.0242	CbGeAlD
Ethacrynic acid—Deafness—Capecitabine—esophageal cancer	0.00366	0.0174	CcSEcCtD
Ethacrynic acid—Hyperuricaemia—Methotrexate—esophageal cancer	0.00362	0.0172	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00346	0.00542	CbGpPWpGaD
Ethacrynic acid—ALB—FOXA2 and FOXA3 transcription factor networks—ALDOB—esophageal cancer	0.00344	0.00539	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—CYP1B1—esophageal cancer	0.00342	0.00537	CbGpPWpGaD
Ethacrynic acid—Blood uric acid increased—Methotrexate—esophageal cancer	0.00342	0.0163	CcSEcCtD
Ethacrynic acid—GSTA2—NRF2 pathway—TGFBR2—esophageal cancer	0.0034	0.00533	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—HMOX1—esophageal cancer	0.00335	0.00525	CbGpPWpGaD
Ethacrynic acid—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00328	0.0156	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.00325	0.0051	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—CYP19A1—esophageal cancer	0.00322	0.00505	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—PRDX1—esophageal cancer	0.0032	0.00501	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—PRDX2—esophageal cancer	0.0032	0.00501	CbGpPWpGaD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.00314	0.00493	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00314	0.00492	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.00308	0.00483	CbGpPWpGaD
Ethacrynic acid—Liver function test abnormal—Capecitabine—esophageal cancer	0.00303	0.0144	CcSEcCtD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.00295	0.00463	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00294	0.00461	CbGpPWpGaD
Ethacrynic acid—Tinnitus—Cisplatin—esophageal cancer	0.00287	0.0136	CcSEcCtD
Ethacrynic acid—Dysphagia—Capecitabine—esophageal cancer	0.00283	0.0135	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00282	0.00442	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00282	0.00442	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.0028	0.00439	CbGpPWpGaD
Ethacrynic acid—Abdominal discomfort—Capecitabine—esophageal cancer	0.00272	0.0129	CcSEcCtD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00267	0.00419	CbGpPWpGaD
Ethacrynic acid—Neutropenia—Capecitabine—esophageal cancer	0.00265	0.0126	CcSEcCtD
Ethacrynic acid—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CALR—esophageal cancer	0.00261	0.00409	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00256	0.00401	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00256	0.00401	CbGpPWpGaD
Ethacrynic acid—Hyperglycaemia—Capecitabine—esophageal cancer	0.00255	0.0121	CcSEcCtD
Ethacrynic acid—ALB—Platelet degranulation—PFN1—esophageal cancer	0.00253	0.00397	CbGpPWpGaD
Ethacrynic acid—Vision blurred—Cisplatin—esophageal cancer	0.00252	0.012	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Cisplatin—esophageal cancer	0.00248	0.0118	CcSEcCtD
Ethacrynic acid—Jaundice—Capecitabine—esophageal cancer	0.00246	0.0117	CcSEcCtD
Ethacrynic acid—Malaise—Cisplatin—esophageal cancer	0.00241	0.0115	CcSEcCtD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—esophageal cancer	0.00241	0.00378	CbGpPWpGaD
Ethacrynic acid—Haematuria—Capecitabine—esophageal cancer	0.00241	0.0114	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Capecitabine—esophageal cancer	0.00236	0.0112	CcSEcCtD
Ethacrynic acid—Convulsion—Cisplatin—esophageal cancer	0.00232	0.011	CcSEcCtD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.0023	0.00361	CbGpPWpGaD
Ethacrynic acid—Anxiety—Cisplatin—esophageal cancer	0.00227	0.0108	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Methotrexate—esophageal cancer	0.00225	0.0107	CcSEcCtD
Ethacrynic acid—Discomfort—Cisplatin—esophageal cancer	0.00225	0.0107	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Cisplatin—esophageal cancer	0.00214	0.0102	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00214	0.00335	CbGpPWpGaD
Ethacrynic acid—Tinnitus—Capecitabine—esophageal cancer	0.00211	0.01	CcSEcCtD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00211	0.0033	CbGpPWpGaD
Ethacrynic acid—Anorexia—Cisplatin—esophageal cancer	0.00208	0.00989	CcSEcCtD
Ethacrynic acid—ALB—Platelet degranulation—CFL1—esophageal cancer	0.00205	0.00322	CbGpPWpGaD
Ethacrynic acid—Chills—Capecitabine—esophageal cancer	0.00203	0.00966	CcSEcCtD
Ethacrynic acid—Abdominal discomfort—Methotrexate—esophageal cancer	0.00202	0.0096	CcSEcCtD
Ethacrynic acid—Neutropenia—Methotrexate—esophageal cancer	0.00197	0.00936	CcSEcCtD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—CFL1—esophageal cancer	0.00195	0.00306	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00194	0.00304	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.00194	0.00304	CbGpPWpGaD
Ethacrynic acid—Decreased appetite—Cisplatin—esophageal cancer	0.0019	0.00902	CcSEcCtD
Ethacrynic acid—Pain—Cisplatin—esophageal cancer	0.00187	0.00887	CcSEcCtD
Ethacrynic acid—Vision blurred—Capecitabine—esophageal cancer	0.00186	0.00883	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Capecitabine—esophageal cancer	0.00183	0.0087	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Cisplatin—esophageal cancer	0.0018	0.00855	CcSEcCtD
Ethacrynic acid—Haematuria—Methotrexate—esophageal cancer	0.00179	0.00851	CcSEcCtD
Ethacrynic acid—Malaise—Capecitabine—esophageal cancer	0.00178	0.00845	CcSEcCtD
Ethacrynic acid—Vertigo—Capecitabine—esophageal cancer	0.00177	0.00842	CcSEcCtD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.00176	0.00276	CbGpPWpGaD
Ethacrynic acid—Agranulocytosis—Methotrexate—esophageal cancer	0.00175	0.00833	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—BLVRB—esophageal cancer	0.00173	0.00271	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—SLC52A3—esophageal cancer	0.00173	0.00271	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Cisplatin—esophageal cancer	0.00173	0.0082	CcSEcCtD
Ethacrynic acid—Anxiety—Capecitabine—esophageal cancer	0.00167	0.00795	CcSEcCtD
Ethacrynic acid—Discomfort—Capecitabine—esophageal cancer	0.00166	0.00788	CcSEcCtD
Ethacrynic acid—Confusional state—Capecitabine—esophageal cancer	0.00162	0.00771	CcSEcCtD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—SOD2—esophageal cancer	0.00158	0.00248	CbGpPWpGaD
Ethacrynic acid—Thrombocytopenia—Capecitabine—esophageal cancer	0.00158	0.00749	CcSEcCtD
Ethacrynic acid—ALB—Platelet degranulation—HSPA5—esophageal cancer	0.00158	0.00247	CbGpPWpGaD
Ethacrynic acid—Tinnitus—Methotrexate—esophageal cancer	0.00157	0.00747	CcSEcCtD
Ethacrynic acid—Asthenia—Cisplatin—esophageal cancer	0.00157	0.00745	CcSEcCtD
Ethacrynic acid—Anorexia—Capecitabine—esophageal cancer	0.00154	0.00729	CcSEcCtD
Ethacrynic acid—Chills—Methotrexate—esophageal cancer	0.00151	0.00719	CcSEcCtD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—HSPA5—esophageal cancer	0.0015	0.00236	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—PTGS1—esophageal cancer	0.0015	0.00235	CbGpPWpGaD
Ethacrynic acid—Diarrhoea—Cisplatin—esophageal cancer	0.00149	0.0071	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—CA1—esophageal cancer	0.00147	0.00231	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—SLC10A2—esophageal cancer	0.00147	0.00231	CbGpPWpGaD
Ethacrynic acid—Decreased appetite—Capecitabine—esophageal cancer	0.0014	0.00665	CcSEcCtD
Ethacrynic acid—Vomiting—Cisplatin—esophageal cancer	0.00139	0.0066	CcSEcCtD
Ethacrynic acid—Fatigue—Capecitabine—esophageal cancer	0.00139	0.0066	CcSEcCtD
Ethacrynic acid—Vision blurred—Methotrexate—esophageal cancer	0.00138	0.00658	CcSEcCtD
Ethacrynic acid—Rash—Cisplatin—esophageal cancer	0.00138	0.00654	CcSEcCtD
Ethacrynic acid—Pain—Capecitabine—esophageal cancer	0.00138	0.00654	CcSEcCtD
Ethacrynic acid—Dermatitis—Cisplatin—esophageal cancer	0.00138	0.00654	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Methotrexate—esophageal cancer	0.00136	0.00647	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—CA2—esophageal cancer	0.00135	0.00211	CbGpPWpGaD
Ethacrynic acid—Feeling abnormal—Capecitabine—esophageal cancer	0.00133	0.0063	CcSEcCtD
Ethacrynic acid—Malaise—Methotrexate—esophageal cancer	0.00132	0.00629	CcSEcCtD
Ethacrynic acid—Vertigo—Methotrexate—esophageal cancer	0.00132	0.00627	CcSEcCtD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00131	0.00206	CbGpPWpGaD
Ethacrynic acid—Nausea—Cisplatin—esophageal cancer	0.0013	0.00616	CcSEcCtD
Ethacrynic acid—ALB—Folate Metabolism—SOD2—esophageal cancer	0.00129	0.00202	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Capecitabine—esophageal cancer	0.00127	0.00605	CcSEcCtD
Ethacrynic acid—Convulsion—Methotrexate—esophageal cancer	0.00127	0.00605	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—PLCE1—esophageal cancer	0.00125	0.00196	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ADH7—esophageal cancer	0.00125	0.00196	CbGpPWpGaD
Ethacrynic acid—Discomfort—Methotrexate—esophageal cancer	0.00124	0.00587	CcSEcCtD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.00124	0.00194	CbGpPWpGaD
Ethacrynic acid—Confusional state—Methotrexate—esophageal cancer	0.00121	0.00574	CcSEcCtD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.0012	0.00188	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.00118	0.00185	CbGpPWpGaD
Ethacrynic acid—Thrombocytopenia—Methotrexate—esophageal cancer	0.00117	0.00558	CcSEcCtD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.00117	0.00184	CbGpPWpGaD
Ethacrynic acid—Asthenia—Capecitabine—esophageal cancer	0.00116	0.00549	CcSEcCtD
Ethacrynic acid—Anorexia—Methotrexate—esophageal cancer	0.00114	0.00543	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.00113	0.00178	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PFN1—esophageal cancer	0.00112	0.00176	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CAPZA1—esophageal cancer	0.00112	0.00176	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00112	0.00175	CbGpPWpGaD
Ethacrynic acid—Diarrhoea—Capecitabine—esophageal cancer	0.0011	0.00523	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—ADH1B—esophageal cancer	0.0011	0.00172	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.0011	0.00172	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.00107	0.00168	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00107	0.00168	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00107	0.00168	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—TYMP—esophageal cancer	0.00105	0.00164	CbGpPWpGaD
Ethacrynic acid—Decreased appetite—Methotrexate—esophageal cancer	0.00104	0.00495	CcSEcCtD
Ethacrynic acid—Fatigue—Methotrexate—esophageal cancer	0.00103	0.00491	CcSEcCtD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.00103	0.00161	CbGpPWpGaD
Ethacrynic acid—Pain—Methotrexate—esophageal cancer	0.00103	0.00487	CcSEcCtD
Ethacrynic acid—Vomiting—Capecitabine—esophageal cancer	0.00102	0.00486	CcSEcCtD
Ethacrynic acid—ALB—Selenium Micronutrient Network—SOD2—esophageal cancer	0.00102	0.0016	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP26A1—esophageal cancer	0.00102	0.0016	CbGpPWpGaD
Ethacrynic acid—Rash—Capecitabine—esophageal cancer	0.00102	0.00482	CcSEcCtD
Ethacrynic acid—Dermatitis—Capecitabine—esophageal cancer	0.00101	0.00482	CcSEcCtD
Ethacrynic acid—Headache—Capecitabine—esophageal cancer	0.00101	0.00479	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—ALOX15—esophageal cancer	0.000994	0.00156	CbGpPWpGaD
Ethacrynic acid—Feeling abnormal—Methotrexate—esophageal cancer	0.000988	0.00469	CcSEcCtD
Ethacrynic acid—Nausea—Capecitabine—esophageal cancer	0.000957	0.00454	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—GSTO1—esophageal cancer	0.000948	0.00149	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—TPI1—esophageal cancer	0.000948	0.00149	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Methotrexate—esophageal cancer	0.000948	0.0045	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—CFL1—esophageal cancer	0.00091	0.00143	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ALDOB—esophageal cancer	0.000909	0.00143	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GAPDH—esophageal cancer	0.000875	0.00137	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CRABP1—esophageal cancer	0.000867	0.00136	CbGpPWpGaD
Ethacrynic acid—Asthenia—Methotrexate—esophageal cancer	0.00086	0.00409	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—GNG7—esophageal cancer	0.000858	0.00135	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GNG7—esophageal cancer	0.000825	0.00129	CbGpPWpGaD
Ethacrynic acid—Diarrhoea—Methotrexate—esophageal cancer	0.00082	0.0039	CcSEcCtD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000812	0.00127	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ALDH2—esophageal cancer	0.000773	0.00121	CbGpPWpGaD
Ethacrynic acid—Vomiting—Methotrexate—esophageal cancer	0.000762	0.00362	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000758	0.00119	CbGpPWpGaD
Ethacrynic acid—Rash—Methotrexate—esophageal cancer	0.000756	0.00359	CcSEcCtD
Ethacrynic acid—Dermatitis—Methotrexate—esophageal cancer	0.000755	0.00359	CcSEcCtD
Ethacrynic acid—Headache—Methotrexate—esophageal cancer	0.000751	0.00357	CcSEcCtD
Ethacrynic acid—ALB—Hemostasis—ATP1B2—esophageal cancer	0.000742	0.00116	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000737	0.00115	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTT1—esophageal cancer	0.000735	0.00115	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP2A6—esophageal cancer	0.000727	0.00114	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000718	0.00113	CbGpPWpGaD
Ethacrynic acid—Nausea—Methotrexate—esophageal cancer	0.000712	0.00338	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—HSPA5—esophageal cancer	0.000699	0.0011	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ENO1—esophageal cancer	0.000689	0.00108	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PTGS1—esophageal cancer	0.000689	0.00108	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000688	0.00108	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000683	0.00107	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PSME1—esophageal cancer	0.000679	0.00106	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PSME2—esophageal cancer	0.000679	0.00106	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—DOCK2—esophageal cancer	0.000671	0.00105	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000642	0.00101	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000609	0.000954	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP1B1—esophageal cancer	0.000586	0.000918	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000581	0.00091	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PFN1—esophageal cancer	0.000579	0.000908	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—PTGS2—esophageal cancer	0.000574	0.000899	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000557	0.000873	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000557	0.000873	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP19A1—esophageal cancer	0.000551	0.000863	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—HMOX1—esophageal cancer	0.000503	0.000788	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000485	0.000761	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ABCB1—esophageal cancer	0.000482	0.000756	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CFL1—esophageal cancer	0.000469	0.000736	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000449	0.000704	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—GNG7—esophageal cancer	0.000442	0.000693	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000431	0.000675	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—TP53—esophageal cancer	0.00043	0.000674	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000423	0.000664	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000422	0.000661	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000383	0.0006	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC52A3—esophageal cancer	0.000376	0.00059	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—BLVRB—esophageal cancer	0.000376	0.00059	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—HSPA5—esophageal cancer	0.000361	0.000565	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000336	0.000527	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CREBBP—esophageal cancer	0.000322	0.000505	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC10A2—esophageal cancer	0.00032	0.000501	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CA1—esophageal cancer	0.00032	0.000501	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CA2—esophageal cancer	0.000293	0.000459	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—NOS3—esophageal cancer	0.000289	0.000453	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000288	0.000451	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000286	0.000448	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ADH7—esophageal cancer	0.000272	0.000426	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PLCE1—esophageal cancer	0.000272	0.000426	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000269	0.000421	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ABL1—esophageal cancer	0.000267	0.000419	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PTGS2—esophageal cancer	0.000264	0.000414	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ADH1B—esophageal cancer	0.000238	0.000374	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000233	0.000366	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—TYMP—esophageal cancer	0.000228	0.000357	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000224	0.000351	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP26A1—esophageal cancer	0.000222	0.000348	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—EP300—esophageal cancer	0.00022	0.000344	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ALOX15—esophageal cancer	0.000216	0.000339	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTO1—esophageal cancer	0.000206	0.000323	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—TPI1—esophageal cancer	0.000206	0.000323	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ALDOB—esophageal cancer	0.000198	0.00031	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—NOS2—esophageal cancer	0.000193	0.000302	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GAPDH—esophageal cancer	0.00019	0.000298	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CRABP1—esophageal cancer	0.000189	0.000296	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GNG7—esophageal cancer	0.000179	0.000281	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CREBBP—esophageal cancer	0.000173	0.000271	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000169	0.000265	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ALDH2—esophageal cancer	0.000168	0.000263	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CA—esophageal cancer	0.000162	0.000255	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTT1—esophageal cancer	0.00016	0.000251	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP2A6—esophageal cancer	0.000158	0.000248	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000157	0.000247	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—NOS3—esophageal cancer	0.000155	0.000243	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTGS1—esophageal cancer	0.00015	0.000235	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ENO1—esophageal cancer	0.00015	0.000235	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.00015	0.000235	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PSME1—esophageal cancer	0.000148	0.000231	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PSME2—esophageal cancer	0.000148	0.000231	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000129	0.000202	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP1B1—esophageal cancer	0.000127	0.0002	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP19A1—esophageal cancer	0.00012	0.000188	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—EP300—esophageal cancer	0.000118	0.000185	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HMOX1—esophageal cancer	0.000109	0.000171	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000107	0.000168	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ABCB1—esophageal cancer	0.000105	0.000164	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CA—esophageal cancer	8.71e-05	0.000137	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TP53—esophageal cancer	8.42e-05	0.000132	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.93e-05	0.000124	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CREBBP—esophageal cancer	7.01e-05	0.00011	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NOS3—esophageal cancer	6.27e-05	9.84e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTGS2—esophageal cancer	5.74e-05	9e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—EP300—esophageal cancer	4.77e-05	7.48e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CA—esophageal cancer	3.53e-05	5.54e-05	CbGpPWpGaD
